Some Investing Thoughts On Altice USA Inc (NYSE: ATUS)

Altice USA Inc (ATUS) concluded trading on Wednesday at a closing price of $2.05, with 4.22 million shares of worth about $8.64 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -37.12% during that period and on Wednesday February 7 the price saw a loss of about -1.44%. Currently the company’s common shares owned by public are about 639.09M shares, out of which, 389.13M shares are available for trading.

According to filings with the U.S. Securities and Exchange Commission (SEC), insiders took part in trade of the company’s stock for 14 times over the past 12 months. They bought 2,068,013 shares in 12 of the transactions. In 2 selling transactions, insiders dumped 1,575,153 shares.

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.

However, the stock later moved at a day high price of 2.1100, or with a loss of -1.44%. Stock saw a price change of -15.98% in past 5 days and over the past one month there was a price change of -35.13%. Year-to-date (YTD), ATUS shares are showing a performance of -36.92% which decreased to -57.64% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $1.75 but also hit the highest price of $4.88 during that period. The average intraday trading volume for Altice USA Inc shares is 4.71 million. The stock is currently trading -17.17% below its 20-day simple moving average (SMA20), while that difference is down -18.17% for SMA50 and it goes to -27.85% lower than SMA200.

Altice USA Inc (NYSE: ATUS) currently have 639.09M outstanding shares and institutions hold larger chunk of about 36.05% of that.

The stock has a current market capitalization of $1.31B and its 3Y-monthly beta is at 1.31. It has posted earnings per share of -$0.05 in the same period. It has Quick Ratio of 0.26. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for ATUS, volatility over the week remained 10.13% while standing at 8.47% over the month.

Analysts are in expectations that Altice USA Inc (ATUS) stock would likely to be making an EPS of $Atossa Therapeutics, Inc. in the current quarter, while forecast for next quarter EPS is $0.95 and it is $Stocks for next year. For the current quarter EPS, analysts have given the company a lowest target $Altice USA, Inc. which is $Astria Therapeutics, Inc. at the higher side of the target for the same. When we compare those targets with actual EPS, we find that company posted an EPS of $ATS Corporation in the same quarter a year ago. Stock’s fiscal year EPS is expected to rise by 12.92% while it is estimated to decrease by -25.61% in next year. EPS is likely to grow at an annualized rate of 6.40% for next 5-years, compared to annual growth of -27.52% made by the stock over the past 5-years.

Most Popular

Related Posts